We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Barr Seeks FDA Approval for Generic Thalomid
Barr Seeks FDA Approval for Generic Thalomid
December 27, 2006
Generic drug firm Barr Pharmaceuticals is seeking FDA approval to market thalidomide, a generic version of Thalomid, a skin defect drug manufactured by Celgene, Barr announced, Dec. 26.